Showing 37 to 48 of 69 results
Boosting Lymphatic System Shows Promise in Preventing Dementia
Researchers have found a potential treatment for cognitive decline that involves boosting the lymphatic system to clear brain waste more efficiently than the body's natural processes, potentially preventing dementia by overcoming the blood-brain barrier.
Boosting Lymphatic System Shows Promise in Preventing Dementia
Researchers have found a potential treatment for cognitive decline that involves boosting the lymphatic system to clear brain waste more efficiently than the body's natural processes, potentially preventing dementia by overcoming the blood-brain barrier.
Progress
44% Bias Score
Gantenerumab Halves Alzheimer's Risk in High-Risk Individuals
A Washington University study found that eight years of gantenerumab treatment halved the risk of Alzheimer's in 22 genetically predisposed individuals, highlighting potential for preventative treatment, but longer-term studies and broader trials are needed.
Gantenerumab Halves Alzheimer's Risk in High-Risk Individuals
A Washington University study found that eight years of gantenerumab treatment halved the risk of Alzheimer's in 22 genetically predisposed individuals, highlighting potential for preventative treatment, but longer-term studies and broader trials are needed.
Progress
44% Bias Score
AI Eye Scans Detect Early Dementia Risk
A new AI technique, Quartz, analyzes retinal blood vessels in eye scans to detect early signs of dementia during routine eye checks, showing links between vessel patterns and cognitive decline in over 63,000 individuals aged 40-69.
AI Eye Scans Detect Early Dementia Risk
A new AI technique, Quartz, analyzes retinal blood vessels in eye scans to detect early signs of dementia during routine eye checks, showing links between vessel patterns and cognitive decline in over 63,000 individuals aged 40-69.
Progress
40% Bias Score
AI System Shows Promise for Early Dementia Detection
Each year, at least 10 million people are diagnosed with dementia worldwide, with 93% being over 65. By 2050, cases may surpass 139 million. A Cambridge University researcher discusses a new AI system for early detection and prevention strategies.
AI System Shows Promise for Early Dementia Detection
Each year, at least 10 million people are diagnosed with dementia worldwide, with 93% being over 65. By 2050, cases may surpass 139 million. A Cambridge University researcher discusses a new AI system for early detection and prevention strategies.
Progress
44% Bias Score
Digital Music Therapy Improves Stroke Recovery
InTandem, a digital platform using Rhythmic Auditory Stimulation (RAS) via music, is now available via prescription for stroke-related gait impairment; developed by Brian Harris at Spaulding Rehabilitation Hospital and now available to the 3.5 million chronic stroke survivors in the US.
Digital Music Therapy Improves Stroke Recovery
InTandem, a digital platform using Rhythmic Auditory Stimulation (RAS) via music, is now available via prescription for stroke-related gait impairment; developed by Brian Harris at Spaulding Rehabilitation Hospital and now available to the 3.5 million chronic stroke survivors in the US.
Progress
24% Bias Score
New Blood Test Trials Aim to Revolutionize Dementia Diagnosis in the UK
NHS clinics in the UK are conducting trials on a new blood test designed to detect early signs of dementia, addressing the current low diagnosis rate (2%) due to limited access to specialized brain scanners and trained staff; the study involves more than 3,000 patients.
New Blood Test Trials Aim to Revolutionize Dementia Diagnosis in the UK
NHS clinics in the UK are conducting trials on a new blood test designed to detect early signs of dementia, addressing the current low diagnosis rate (2%) due to limited access to specialized brain scanners and trained staff; the study involves more than 3,000 patients.
Progress
56% Bias Score
EMA Blocks Alzheimer's Drug Donanemab Due to Fatal Side Effects
The European Medicines Agency (EMA) blocked Lilly's Alzheimer's drug, donanemab (Kisunla), due to potentially fatal side effects, despite its approval in the US and UK; the drug slowed Alzheimer's progression by 35% in trials but caused three deaths, two linked to a gene increasing Alzheimer's risk;...
EMA Blocks Alzheimer's Drug Donanemab Due to Fatal Side Effects
The European Medicines Agency (EMA) blocked Lilly's Alzheimer's drug, donanemab (Kisunla), due to potentially fatal side effects, despite its approval in the US and UK; the drug slowed Alzheimer's progression by 35% in trials but caused three deaths, two linked to a gene increasing Alzheimer's risk;...
Progress
52% Bias Score
Revised Timeline in Hackman Deaths
The timeline of the deaths of actor Gene Hackman and his wife Betsy Arakawa in Santa Fe, New Mexico has been revised after the discovery of cell phone data showing Arakawa used her phone on February 12th, which contradicts the previous assumption that her last known activity was on February 11th. Ar...
Revised Timeline in Hackman Deaths
The timeline of the deaths of actor Gene Hackman and his wife Betsy Arakawa in Santa Fe, New Mexico has been revised after the discovery of cell phone data showing Arakawa used her phone on February 12th, which contradicts the previous assumption that her last known activity was on February 11th. Ar...
Progress
20% Bias Score
Loss of Smell Linked to Increased Dementia Risk
A study reveals a strong link between loss of smell (anosmia or hyposmia) and increased dementia risk, with prevalence significantly rising with age; early detection is crucial, as anosmia is often irreversible if caused by neurodegeneration.
Loss of Smell Linked to Increased Dementia Risk
A study reveals a strong link between loss of smell (anosmia or hyposmia) and increased dementia risk, with prevalence significantly rising with age; early detection is crucial, as anosmia is often irreversible if caused by neurodegeneration.
Progress
48% Bias Score
U.S. Caregiver Crisis: Financial Strain and Inadequate Support
In the U.S., 48 million unpaid family caregivers shoulder a $600 billion annual burden, facing financial hardship and limited support despite programs like Medicaid, as illustrated by Janice and Brandon Will's struggle with Parkinson's disease and insufficient Medicaid coverage in Illinois.
U.S. Caregiver Crisis: Financial Strain and Inadequate Support
In the U.S., 48 million unpaid family caregivers shoulder a $600 billion annual burden, facing financial hardship and limited support despite programs like Medicaid, as illustrated by Janice and Brandon Will's struggle with Parkinson's disease and insufficient Medicaid coverage in Illinois.
Progress
36% Bias Score
Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study
A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.
Ozempic and Wegovy May Reduce Risk of Multiple Diseases: Large-Scale Study
A study of 1.2 million veterans' health records suggests that Ozempic and Wegovy, GLP-1 receptor agonists, may reduce risks of schizophrenia, Alzheimer's, and substance abuse, although further research is needed due to the study's limitations.
Progress
52% Bias Score
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
Progress
52% Bias Score
Showing 37 to 48 of 69 results